Submandibular gland transfer for prevention of xerostomia after radiation therapy: Swallowing outcomes

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 2, 2005, Pages 140-145

  Rieger, Jana ^a,c   Seikaly, Hadi ^a,b   Jha, Naresh ^b   Harris, Jeffrey ^a   Williams, David ^a   Liu, Richard ^a   McGaw, Tim ^a   Wolfaardt, John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c Misericordia Community Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD CANCER; HUMAN; MALE; NECK CANCER; OROPHARYNX CANCER; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; SALIVATION; SUBMANDIBULAR GLAND; SURGICAL TECHNIQUE; SWALLOWING; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; SUBMANDIBULAR GLAND; XEROSTOMIA;

EID: 13444270708     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.2.140     Document Type: Article

References (25)

1. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer. 1997;5:281-288.
2. Vissink A, Panders AK, Gravenmade EJ, Vermey A. The causes and consequences of hyposalivation. Ear Nose Throat J. 1988;67:166-176.
3. Hughes CV, Baum BJ, Fox PC, Marmary Y, Yen CK, Sonies BC. Oral-pharyngeal dysphagia: a common sequela of salivary gland dysfunction. Dysphagia. 1987;1:173-177.
4. Ohrn KE, Wahlin YB, Sjoden PO. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer. 2001;9:247-257.
5. Hamburger J. Sjogren's syndrome as seen by an oral physician. Scand J Rheumatol Suppl. 2001;115:34-38.
6. Young W, Khan F, Brandt R, Savage N, Razek AA, Huang Q. Syndromes with salivary dysfunction predispose to tooth wear: case reports of congenital dysfunction of major salivary glands, Prader-Willi, congenital rubella, and Sjogren's syndromes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:38-48.
7. Logemann JA, Smith CH, Pauloski BR, et al. Effects of xerostomia on perception and performance of swallow function. Head Neck. 2001;23:317-321.
8. Hamlet S, Faull J, Klein B, et al. Mastication and swallowing in patients with post-irradiation xerostomia. Int J Radiat Oncol Biol Phys. 1997;37:789-796.
9. Logemann JA, Pauloski BR, Rademaker AW, et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck. 2003;25:432-437.
10. Seikaly H, Jha N, McGaw T, Coulter L, Liu R, Oldring D. Submandibular gland transfer: a new method of preventing radiation-induced xerostomia. Laryngoscope. 2001;111:347-352.
11. Specht L. Oral complications in the head and neck radiation patient: introduction and scope of the problem. Support Care Cancer. 2002;10:36-39.
12. Wescott WB, Mira JG, Starcke EN, Shannon IL, Thornby JI. Alterations in whole saliva flow rate induced by fractionated radiotherapy. AJR Am J Roentgenol. 1978;130:145-149.
13. Hughes PJ, Scott PM, Kew J, et al. Dysphagia in treated nasopharyngeal cancer. Head Neck. 2000;22:393-397.
14. Ramirez-Amador V, Silverman S Jr, Mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:149-153.
15. Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol. 2001;19:1961-1969.
16. Warde P, Kroll B, O'Sullivan B, et al. A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Support Care Cancer. 2000;8:203-208.
17. Jha N, Seikaly H, McGaw T, Coulter L. Submandibular salivary gland transfer prevents radiation-induced xerostomia. Int J Radiat Oncol Biol Phys. 2000;46:7-11.
18. Jha N, Seikaly H, Harris J, et al. Prevention of radiation-induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 2003;66:283-289.
19. Seikaly H, Jha N, Barnaby P, et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol Head Neck Surg. 2004;130:956-961.
20. Izutsu KT, Truelove EL, Bleyer WA, Anderson WM, Schubert MM, Rice JC. Whole saliva albumin as an indicator of stomatitis in cancer therapy patients. Cancer. 1981;48:1450-1454.
21. Stachler RJ, Hamlet SL, Mathog RH, et al. Swallowing of bolus types by post-surgical head and neck cancer patients. Head Neck. 1994;16:413-419.
22. Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 1996;106:1157-1166.
23. Lof GL, Robbins J. Test-retest variability in normal swallowing. Dysphagia. 1990;4:236-242.
24. Robbins J, Coyle J, Rosenbek J, Roecker E, Wood J. Differentiation of normal and abnormal protection during swallowing using the Penetration- Aspiration Scale. Dysphagia. 1999;14:228-232.
25. Davis MP, Dickerson D. Cachexia and anorexia: cancer's covert killer. Support Care Cancer. 2000;8:180-187.